| LECTURES
|
| Friday,
December 13, 2002 |
| Time |
Title |
Speaker |
|
 |
| 8:30 |
Introduction
|
Joseph A.
Smith, Jr., M.D
President, SUO
W. Marston Linehan,
M.D
Program Director |
|
|
8:40-
9:30 |
Bladder
Cancer I: Management of Recurrent Disease after BCG Failure |
Mark
Soloway, M.D
Moderator |
|
| |
|
BCG
Failure or Iatrogenic Immunosuppression: Definitions, Pitfalls, and
Pearls |
Donald
Lamm, M.D |
|
| |
|
Updated Results
of Combination Low-Dose BCG Plus Interferon for BCG Failures |
Michael O'Donnell,
M.D |
|
| |
|
Vaccine Therapy
for Bladder Cancer BCG to Gene Therapy: Prospects for the Future |
Timothy Ratliff,
Ph.D. |
|
| |
|
Surgical Variables
Impact Bladder Cancer Outcomes |
Harry Herr, M.D |
|
| |
|
Discussion Panelists:
Soloway, Lamm, O'Donnell, Ratliff, Herr |
|
|
|
9:40-
10:00 |
NCI
Program |
|
|
| |
|
Prostate and
GU SPOREs |
Jorge Gomez,
M.D., Ph.D. |
|
| |
|
NCI Kidney/Bladder
Progress Review Group |
Nicholas Vogelzang,
M.D. |
|
|
|
10:00-
10:40 |
Poster
Session I: Bladder and Kidney I |
|
|
|
|
10:40-
11:40 |
Bladder
Cancer II: Molecular Genetics of Bladder Cancer: Ready for Prime Time? |
Michael Koch,
M.D.
Moderator |
|
| |
|
Molecular Genetics
of Bladder Cancer Clinical Implications |
Carlos Cordon-Cardo,
M.D., Ph.D. |
|
| |
|
Markers for Bladder
Cancer: Where Are We? Where Are We Going? |
Ralph deVere
White, M.D. |
|
| |
|
Lymph Node Density
as a Prognostic Marker |
John Stein, M.D. |
|
| |
|
Genetic Alterations/Gene
Therapy Bladder Cancer |
Raffaelle Baffa,
M.D. |
|
| |
|
Discussion Panelists:
Koch, Cordon-Cardo, deVere White, Stein, Baffa |
|
|
|
| 11:40-1:00 |
Poster
Session 2: Kidney 2 and Prostate 1 |
|
|
|
| 1:00 |
Special
Address
Seamless Urologic Oncology: Mapping the Future |
Andrew von Eschenbach,
M.D.
Director, National Cancer Institute |
|
|
| 1:20 |
Huggins
Medal Presentation |
Joseph A. Smith,
M.D.
Paul Schellhammer, M.D. |
|
|
| 1:30 |
Huggins
Lecture
Prostate Disease/Urologic Oncology:
Personal Experience and Random Thoughts in a Half Century of Involvement |
John Grayhack,
M.D. |
|
|
2:00-
2:25 |
UroPathology |
|
|
| |
|
Introduction |
Maria Merino,
M.D. |
|
| |
|
Kidney Cancer |
Victor Reuter,
M.D. |
|
|
2:25-
3:10 |
Kidney
Cancer I: Role of Radical Nephrectomy in Patients with Advanced
Disease |
David Wood, M.D.
Moderator |
|
| |
|
Radical Nephrectomy
with Mets: Pro |
Robert Flanigan,
M.D. |
|
| |
|
Radical Nephrectomy
with Mets: Con |
Robert Dreicer,
M.D. |
|
| |
|
Discussion Panelists:
Wood, Swanson, Flanigan, Thompson, Dreicer |
|
|
|
3:10-
3:50 |
Poster
Session 3: Prostate 2 |
|
|
|
3:50-
4:35 |
Kidney
Cancer II: Treatment of Patients with Advanced Disease |
Ian Thompson,
M.D.
Moderator |
|
| |
|
Allogeneic Stem
Cell Update |
Richard Childs,
M.D. |
|
| |
|
National Trials
in Advanced RCC |
Nicholas Vogelzang,
M.D. |
|
| |
|
New Strategies
for Prognostication and Treatment of Advanced RCC |
Arie Belldegrun,
M.D. |
|
| |
|
Discussion Panelists:
Thompson, Childs, Vogelzang, Belldegrun |
|
|
|
|
| |
|
|
|
|
| Saturday,
December 14, 2002 |
| Time |
Title |
Speaker |
|
|
8:00-
9:10 |
Prostate
Cancer I: Advanced Disease |
Martin Sanda,
M.D.
Moderator |
|
| |
|
Immunotherapy
of Prostate Cancer |
Neil Bander,
M.D. |
|
| |
|
New Strategies
for Vaccine Therapy |
Jeffrey Schlom,
Ph.D. |
|
| |
|
Dendritic Cell
Therapy for GU Malignancies |
Johannes Vieweg,
M.D. |
|
| |
|
Calcitrol in
Advanced Prostate Cancer |
Tomasz Beer,
M.D. |
|
| |
|
Discussion Panelists:
Sanda, Bander, Schlom, Vieweg, Beer |
|
|
|
9:10-
10:05 |
Testis
Cancer |
Judd Moul, M.D.
Moderator |
|
| |
|
Surveillance
for Testicular Cancer in 2002/Seminoma/Non-Seminoma |
Mary Gospodarowicz,
M.D. |
|
| |
|
Anatomy, Technique,
and Results of Laparoscopic Retroperitoneal Lymph Node Dissection |
Georg Bartsch,
M.D. |
|
| |
|
Hereditary Testicular
Cancer: Clinical Implications |
Mark Greene,
M.D. |
|
| |
|
Discussion Panelists:
Moul, Gospodarowicz, Bartsch, Greene |
|
|
|
|
10:05-
10:15 |
Poster
Session Awards |
Michael Cher,
M.D.,
Leonard Gomella, M.D.,
John Phillips, M.D. |
|
|
10:15-
11:15 |
Prostate
Cancer II: Early versus Late Hormonal Therapy for Biochemical Failure |
David Crawford,
M.D.
Moderator |
|
| |
|
Early Hormonal
Therapy for Biochemical Failure |
Martin Gleave,
M.D. |
|
| |
|
Late Hormonal
Therapy for Biochemical Failure |
Edward Messing,
M.D. |
|
| |
|
Discussion Panelists:
Crawford, Gleave, Messing |
|
|
|
11:15-
Noon |
Prostate
Cancer III: Laparoscopic Radical Prostatectomy: Are We Making Progress? |
Leonard Gomella,
M.D.
Moderator |
|
| |
|
Lap Prostatectomy:
An Evolving Art |
Mani Menon, M.D. |
|
| |
|
Limitations of
Laparoscopic Prostatectomy |
Maxwell V. Meng,
M.D. |
|
| |
|
Discussion Panelists:
Gomella, Menon, Meng |
|
|
|
| Noon |
Concluding
Remarks and Adjourn |
Joseph A. Smith,
Jr., M.D. |
|
|
